Projected Timeline Retatrutides commercial timeline is a multi-step journey molded by international regulatory guidelines and clinical results
You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you
[5] Any insulin dose adjustments should only be made under clinical supervision
Many of the cardiovascular, renal, and hepatic benefits of semaglutide, sold as Ozempic and Wegovy, appear to occur independently of weight loss or glucose improvement, he notes
Taking a GLP-1 medication plus a hypothetical GIP medication separately wouldnt necessarily produce the same effects as a designed dual agonist, and this approach hasnt been studied
Future Candidates for Retatrutide Once it successfully clears regulatory hurdles, retatrutide may become preferred for: Individuals with severe obesity who have plateaued on dual-agonist or mono-agonist therapies